Drugplain

Premier Value Max Strength Antibiotic plus pain relief 3.5 mg/g

Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL · CREAM · Pharmacy Value Alliance LLC

No Recall History
Plain English

Premier Value Max Strength Antibiotic plus pain relief is a cream containing premier value neomycin sulfate, polymyxin b sulfate, pramoxine hcl at 3.5 mg/g, taken topical. Manufactured by Pharmacy Value Alliance LLC.

Key Facts

Brand Name
Premier Value Max Strength Antibiotic plus pain relief
Generic Name
Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL
NDC Code (Product)
68016-296
Manufacturer
Pharmacy Value Alliance LLC
Strength
3.5 mg/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
09/22/2019

Recall History

No Recall History

Frequently Asked Questions

What is Premier Value Max Strength Antibiotic plus pain relief used for?

Premier Value Max Strength Antibiotic plus pain relief contains Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL. It is a cream taken topical. Consult your doctor for specific uses.

Is Premier Value Max Strength Antibiotic plus pain relief a controlled substance?

Premier Value Max Strength Antibiotic plus pain relief is not classified as a controlled substance by the DEA.

What is the generic name for Premier Value Max Strength Antibiotic plus pain relief?

The generic name for Premier Value Max Strength Antibiotic plus pain relief is Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL. There are no other listed brand versions of Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL.

What is the NDC code for Premier Value Max Strength Antibiotic plus pain relief 3.5 mg/g?

The NDC (National Drug Code) for Premier Value Max Strength Antibiotic plus pain relief 3.5 mg/g is 68016-296, listed by Pharmacy Value Alliance LLC.

Product NDC

68016-296

Package NDC

68016-296-05

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)